New hope for controlling severe heart failure?
NCT ID NCT07444398
Summary
This study is testing if adding a drug called vericiguat to standard heart failure treatment helps people with a severe, sudden worsening of their condition. It will involve 130 patients who are hospitalized with severe symptoms. The main goal is to see if the drug reduces the need for future hospital stays or death from heart-related causes over three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Armed Forces Institute of Cardiology. Pakistan
RECRUITINGRawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.